The Circuit Court of Appeals for the District of Columbia decided Tuesday afternoon to allow federally funded human embryonic stem cell research to continue, while the federal government appeals a lower court injunction that barred the work.
Recent Posts
- Ketogenic Diet Enhances CAR-T Cancer Therapy
- Socioeconomic Barriers Limit Access to Lifesaving Stem Cell Transplants in AML
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy